Evidence map›Paper›PMID 25832550›Full record

ArticleJournal of internal medicine2015

The role of microRNA in nutritional control.

E N M Nolte-'t Hoen, E Van Rooij, M Bushell, C-Y Zhang, R H Dashwood, W P T James, C Harris, D Baltimore

Open access · bronzeAbstract read
In one paragraph

Article in Journal of internal medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. A clinical nutritionist's experience and expectations.European journal of clinical nutrition · 2017
    Article
  12. Review
  13. Circulating MicroRNAs as Potential Biomarkers of Exercise Response.International journal of molecular sciences · 2016
    Review
  14. Stress and Protists: No life without stress.European journal of protistology · 2016
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 5 countries.

E N M Nolte-'t HoenDepartment of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
E Van RooijHubrecht Institute, Koninklijke Nederlandse Academie van Wetenschappen (KNAW), University Medical Center Utrecht, Utrecht, The Netherlands.
M BushellMedical Research Council (MRC) Toxicology Unit, University of Leicester, Leicester, UK.
C-Y ZhangJiangsu Engineering Research Center for microRNA Biology and Biotechnology, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
R H DashwoodCenter for Epigenetics and Disease Prevention, Institute of Biosciences & Technology, Texas A&M Health Science Center, Houston, TX, USA.
W P T JamesLondon School of Hygiene and Tropical Medicine, London, UK.
C HarrisLaboratory of Human Carcinogenesis, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
D BaltimoreDepartment of Biology, California Institute of Technology, Pasadena, CA, USA.
California Institute of Technology · USChina Pharmaceutical University · CNLondon School of Hygiene & Tropical Medicine · GBMRC Toxicology Unit · GBNational Institutes of Health · USPrevention Institute · USRoyal Netherlands Academy of Arts and Sciences · NLUtrecht University · NL

Funding

Transplacental Chemoprevention of Lung Tumors and LymphomasP01CA090890 · NCI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DASHWOOD, RODERICK H · 2003 to 2014
$14.2M
Dietary HDAC Inhibitors in Colon Cancer PreventionR01CA122959 · NCI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DASHWOOD, RODERICK H · 2008 to 2023
$4.3M
Medical Research Council MC_EX_G0902052Medical Research Council MC_UP_A600_1024NCI NIH HHS P01 CA090890NCI NIH HHS R01 CA122959
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are one of a growing class of noncoding RNAs that are involved in the regulation of a wide range of metabolic processes including cellular differentiation, cell proliferation and apoptosis. The generation of miRNA is regulated in complex ways, for example by small interfering RNAs (small nucleolar and nuclear RNAs) and various other metabolites. This complexity of control is likely to explain how a relatively small part of the DNA that codes for proteins has enabled the evolution of such complex organisms as mammals. Non-protein-coding DNA is therefore thought to carry the memory of early evolutionary steps that led to progressively complex metabolic controls. Clinically, miRNAs are becoming increasingly important following the recognition that some congenital abnormalities can be traced to defects in miRNA processing. The potential for manipulating metabolism and affecting disease processes by the pharmaceutical or biological targeting of specific miRNA pathways is now being tested. miRNAs are also released into the extracellular milieu after packaging by cells into nano-sized extracellular vesicles. Such vesicles can be taken up by adjacent and possibly more distant cells, thereby allowing coordinated intercellular communication in specific tissues. Extracellular miRNAs found in the blood stream may also serve as novel biomarkers for both diagnosing specific forms of cancer and assessing the likelihood of metastasis, and as powerful prognostic indices for various cancers. Here, we discuss the role of intracellular and extracellular miRNAs in nutritional control of various (patho)physiological processes. In this review, we provide an update of the presentations from the 25th Marabou Symposium (Stockholm, 14-16 June 2013) entitled 'Role of miRNA in health and nutrition', attended by 50 international experts

Indexed as

Nutrition AssessmentAnimalsCell CommunicationHumansMicroRNAsNeoplasmsPrognosisMicroRNAsdevelopmentmetabolic controlmiRNAnutritionpathologysignalling

Identifiers

PMID25832550
PMCPMC12910441
OpenAlexW2055201148

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.